Index Symptoms and Prognosis Awareness of Patients With Pancreatic Cancer: A Multi-Site Palliative Care Collaborative

Abstract

Background: Pancreatic cancer has a poor 5-year survival and carries significant morbidity. Pain is a commonly studied symptom in pancreatic cancer; however, few studies examine the frequency of multiple patient-reported symptoms. Our aim is to ascertain patient-reported symptom burden at initial consultation with a palliative care provider and compare patient prognostic awareness to provider estimation of prognosis. Methods: Data were extracted from the standardized Quality Data Collection Tool (QDACT). Adults with pancreatic cancer seen by a palliative care provider were included. Descriptive statistics were used to describe demographic features, symptom prevalence and burden, as well as assess patient prognosis awareness defined by congruence or incongruence with provider estimated prognosis. Results: 285 patients were included in our analysis. The average age was 68 years (SD: 12.4), 87.2% were white, 50% male. The mean number of moderate/severe symptoms was 2.6 (SD: 2) out of 9 symptoms. Tiredness (66.7%), appetite (64.5%) and pain (46.2%) had the highest rates of moderate/severe symptom burden. Patients with a prognosis of 1-6 months had the lowest proportion of congruence with provider estimation (56.5%). Conclusion: Our study suggests targets to improve patient-centered care of pancreatic cancer. Patients commonly have multiple symptoms that are moderate/severe at time of palliative care referral. While pain has been well-reported, tiredness and decreased appetite are more prevalent at initial visit. This emphasizes the importance of assessing multiple symptoms and working closely with palliative care for early referral. Overall, one third of patient prognosis estimates differed from the provider assessment of prognosis. Our data support the importance of early referral to palliative care to manage symptoms and better prepare patients for end-of-life care.

Development and psychometric evaluation of the death risk perception scale for advanced cancer patients

“…Individual risk perception is also influenced by past experiences and cognitive judgments. Studies have shown that factors like trust in doctors and confidence in treatment effectiveness can impact risk perception [ 38 – 40 ]. Some qualitative studies [ 31 , 41 ] have revealed that some advanced patients with cancer believe that it inevitably leads to death, resulting in a high level of death risk perception, even if treatment is effective.…”

Research progress on microRNAs as molecular markers in pancreatic cancer: a narrative review

“…The clinical features of PC are not significant. PC has many symptoms, including jaundice, back/abdominal pain, loss of appetite, and weight loss (5). Additionally, PC is extremely aggressive, metastatic, and chemotherapy-resistant (6).…”